Published in J Antimicrob Chemother on August 01, 1995
A chemically defined medium for slime production by coagulase-negative staphylococci. J Med Microbiol (1991) 1.74
Fatal transfusion reaction due to Yersinia enterocolitica. J Hosp Infect (1994) 1.40
MRSA bacteraemia. J Hosp Infect (1997) 1.38
Plasmid-mediated vanB glycopeptide resistance in enterococci. Microb Drug Resist (1995) 1.26
Isolation and composition of the extracellular slime made by coagulase-negative staphylococci in a chemically defined medium. J Infect Dis (1991) 1.14
Comparison of cell-wall teichoic acid with high-molecular-weight extracellular slime material from Staphylococcus epidermidis. J Med Microbiol (1992) 1.08
Coagulase negative staphylococcal infections. Br Med J (Clin Res Ed) (1985) 1.06
The role of extracellular slime in opsonophagocytosis of Staphylococcus epidermidis. J Med Microbiol (1988) 1.03
Radiochemical assay to measure the biofilm produced by coagulase-negative staphylococci on solid surfaces and its use to quantitate the effects of various antibacterial compounds on the formation of the biofilm. J Med Microbiol (1992) 1.00
Vancomycin-dependent enterococci in the United Kingdom. J Antimicrob Chemother (1994) 0.94
A novel luminometer for rapid antimicrobial susceptibility tests on gram-positive cocci by ATP bioluminescence. J Med Microbiol (1989) 0.85
Rapid antibiotic susceptibility tests on Enterobacteriaceae by ATP bioluminescence. J Med Microbiol (1988) 0.85
Penicillin-aminoglycoside synergy and post-antibiotic effect for enterococci. J Antimicrob Chemother (1989) 0.85
Measuring pre- and post-dose vancomycin levels--time for a change? J Med Microbiol (1995) 0.82
Patterns of carriage of group B streptococci in genitourinary medicine clinic patients. Genitourin Med (1988) 0.81
Antimicrobial susceptibility testing of mycoplasmas by ATP bioluminescence. J Med Microbiol (1991) 0.80
Fungal colonisation and fluconazole therapy in acute liver disease. Liver (1998) 0.80
Slime production by coagulase negative staphylococci--a major virulence factor? Contrib Nephrol (1987) 0.78
Safety of high-dose amphotericin B lipid complex. Bone Marrow Transplant (1999) 0.77
Rotavirus detection using ultrasound enhanced latex agglutination and turbidimetry. J Immunoassay (2000) 0.76
Pseudomonal breast infection. Ann R Coll Surg Engl (2010) 0.76
Targeted prophylaxis with amphotericin B lipid complex in liver transplantation. Liver Transpl (2000) 0.76
Synergy between penicillin and gentamicin against enterococci. J Antimicrob Chemother (1990) 0.75
Bacterial endocarditis: a complication of gastroscopy. Br Med J (Clin Res Ed) (1988) 0.75
Enterococcal meningitis in an HIV positive haemophilic patient. J Clin Pathol (1991) 0.75
Is repeated flushing of Hickman catheters necessary? Br Med J (Clin Res Ed) (1985) 0.75
Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review. J Antimicrob Chemother (1999) 0.75
MRSA in non-clinical areas of hospitals. J Hosp Infect (2006) 0.75
Respiratory viruses in adult liver transplant recipients. Transplantation (1999) 0.75
Therapeutic progress. IV: Treatment and prophylaxis of Pneumocystis carinii infection. J Clin Pharm Ther (1995) 0.75
Are lanyards a risk for nosocomial transmission of potentially pathogenic bacteria? J Hosp Infect (2008) 0.75